<International Circulation>:  What is the best criterion for choosing that team and putting that together?

   《国际循环》：选择团队并且把他们合并在一起的最好标准是什么？ 
      Prof. Brindis:   In the case of TAVI， one of the challenges we are going to have going forward is how， us as a cardiovascular profession， to responsibly help the FDA and end-payers in the diffusion of new innovative technology.  Not every hospital for example should be doing or performing trans-aortic valve implantation.  The professional societies appreciate this and are developing competency statements in partnership with the Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC)， and the Society of Coronary Artery Intervention (SCAI) are all going to be able to help advise payers， the government， and the FDA in how we can be responsible in the introduction of these technologies.  Part of that as you point out is the development of a multi-expert team of expert surgeons， expert interventionalists， expert echocardiographers， as well as cardiac care associates such as nurses and physician assistants as a team to be able to take best care of these patients.

   Brindis教授：对于TAVI，我们面临的挑战之一是：作为一个心血管专家，如何以负责任的态度，帮助FDA和投资者扩展新的创新技术，例如不是每个医院都应该做或能做主动脉瓣置换术。专业协会对此表示赞赏，并正与胸外科医师学会（STS）及美国心脏病学会（ACC）以及冠状动脉介入学会（SCAI）制定资格声明，这些组织都能帮助提醒纳投资者、政府以及美国FDA??关于我们如何负责任地引进这些技术。这部分正如你们所指出：发展由外科专家、介入专家、心脏超声专家以及护士和助理医生组成的医疗专家团队能够为患者提供最好的医疗护理。